Abstract
Auranofin [2,3,4,6-tetra-0-acetyl-1-thio-β-D-glucopyranosato-S)-(triethylphosphine)gold], a new gold compound for treating rheumatoid arthritis (RA), is unique in that it produces its therapeutic benefit when administered by the oral route. Currently used gold preparations (sodium aurothiomalate, aurothioglucose) must be given by injection to be effective. Auranofin has been used in the treatment of RA patients in clinical trials, and is comparable in efficacy to presently used injectable agents. Side effects with auranofin are mild in nature and result in fewer withdrawals from therapy than do injectable gold preparations.
Similar content being viewed by others
References
Empire Rheumatic Council Subcommittee, ‘Gold therapy in rheumatoid arthritis’,Ann. Rheum. Dis., 1960,19, 95–119
Cooperative Clinics Committee of the American Rheumatism Association, ‘A controlled trial of gold salt therapy in rheumatoid arthritis’,Arthritis and Rheum., 1973,16, 353–358
B.M. Sutton, E. McGusty, D.T. Waltz and M.J. DiMartino, ‘Oral gold antiarthritic properties of alkylphosphinegold coordination complexes’,J. Med. Chem., 1972,15, 1095–1098
R.C. Blodgett Jr., M.A. Heuer and R.G. Pietrusko, ‘Auranofin. A unique oral chrysotherapeutic agent’,Semin. Arthritis Rheum., 1984,13, 255–273
G.M. Dyson, ‘Gold in chemistry and pharmacy. I The metal and its history’,Pharm. J., 1929,123, 249–250, 266–267
J.C. Burnett, ‘Gold as a remedy in disease’, The Homeopathic Publishing Company, London, 1879, pp. 28, 127
R. Koch, ‘Ueberbackteriologische Forschung’,Wein. Med. Bl., 1890,13, 531–535
P.D. Hart, ‘Chemotherapy of tuberculosis. Research during the past 100 years’,Brit. Med. J., 1946,2, 805, 849
J. Forestier, ‘Rheumatoid arthritis and its treatment with gold salts. The results of six years’ experience’,J. Lab. Clin. Med., 1935,20, 827–40.
J.W. Sigler, G.B. Bluhm, H. Duncan, J.T. Sharp, D.C. Ensign and W.R. McCrum, ‘Gold salts in the treatment of rheumatoid arthritis’,Ann. Intern. Med., 1974,80, 21–26
G.P. Rodnan. C. McEwen and S.L. Wallace, ‘Primer on the rheumatic diseases’,J. Am. Med. Assoc., 1973,224, 661–812
N.J. Zvaifler, ‘Gold and antimalarial therapy’, in ‘Arthritis and allied conditions’, edited by D.J. McCarthy, 9thEd., Iea and Febiger, Philadelphia, 1979, pp. 364–367
See (12) p. 417
A.D. Steinberg and J.L Decker, ‘Imunnoregularatory drugs’, in ‘Arthritis and Allied Conditions’, edited by D.J. McCarthy, 9th Ed., Lea and Febiger, Philadelphia, 1979, pp. 375–390
B.M. Sutton, ‘Overview and current status of gold-containing antiarthritis drugs’, in ‘Platinum, Gold and Other Metal Chemotherapeutic Agents. ACS Sym. Series 209’, Am. Chem. Soc., edited by S.L. Lippart, Washington D.C. 1983, pp. 355–369
Author information
Authors and Affiliations
Additional information
This article is a slightly revised version of a paper first given at an IPMI conference, June 13th, 1985 and is reprinted by kind permission of the IPMI.
Rights and permissions
About this article
Cite this article
Sutton, B.M. Gold compounds for rheumatoid arthritis. Gold Bull 19, 15–16 (1986). https://doi.org/10.1007/BF03214639
Issue Date:
DOI: https://doi.org/10.1007/BF03214639